Biotech IPOs begin to pick back up in Q2. This and more in this week’s life sciences update. … READ MORE >
Life sciences
Biopharma markets thaw: M&A and fundraising accelerate
Dealmaking and capital formation in the biopharma sector are gaining momentum. … READ MORE >
New 100% tariff announced for branded pharmaceutical products
To evaluate the impact of applying most favored nation pricing, companies should look at global sales strategies, gross-to-net pricing and existing transfer pricing arrangements. … READ MORE >
5 things to know in life sciences: Week of April 6, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of March 30, 2026
Accelerator program selects early-stage life sciences startups to fuel next-gen innovation. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of March 23, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of March 16, 2026
FDA provides new guidance to replace animal testing in early drug studies. This and more in this week’s life sciences update. … READ MORE >
UK VAT ruling could unlock refunds for U.S. biopharma companies
The outcome of the case could unlock millions of pounds in VAT reclaims for U.S. biopharma companies with UK operations. … READ MORE >
5 things to know in life sciences: Week of March 9, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of March 2, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >